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Abstract
In late 2019 a newly identified strain of coronavirus, SARS-CoV-2 emerged, causing a worldwide pandemic of respiratory illness,
Covid-19. Covid-19 has drastically transformed the world in numerous ways.The virus is highly contagious and, in some cases, fatal.
A successful cure has not yet been discovered and therefore society is urged to take proper precautions to prevent the spread of
the potentially fatal virus. This paper analyzes the proper precautions that should be taken as well as the ongoing research that
has been done to stop the spread of the virus.
Introduction
The novel Corona Virus, the underlying cause of Covid19, is an infectious virus that primarily affects the respiratory tract. It was first diagnosed in 2019 in Wuhan, China
where thousands of people were stricken with the virus.
The virus eventually spread across the globe and was
eventually categorized as a global pandemic. Symptoms of
Covid-19 include fever, cough, difficulty breathing, shortness of breath, muscle fatigue, and loss of smell or taste.
Recent studies revealed that Coronavirus impacts the
gastrointestinal tract causing nausea, vomiting and diarrhea (Clinical Trials Week, 2020). While most people with
the virus portray mild symptoms, a small but significant
percentage of people develop more serious symptoms
such as pneumonia which can be fatal. Elderly people,
individuals with preexisting health conditions, as well as
people with compromised immune systems are at the
greatest risk for developing the most serious symptoms.
The virus is highly contagious and spreads, most commonly, through small droplets via coughing and sneezing.
Additionally, people may catch the virus by touching a surface that is contaminated, followed by then touching their
face (Mohan, 2021). Therefore, the Centers for Disease
Control (CDC) enforce face coverings such as masks or
bandanas to minimize transmission through droplets. The
CDC strongly recommends people to properly social distance and stay six feet apart from each other to prevent
the spread of the virus. Additionally, people are advised to
constantly wash their hands with soap for roughly twenty
seconds to rid themselves of any viral particles that they
may have encountered.
Symptoms may not develop for two to seven days
after coming in contact with the virus, which may make
affected people unaware that they are infected, and which
strongly contributes to the mass spread of the virus.
Although Covid-19 is highly contagious, it is most contagious during the first three days that the patient exhibits
symptoms. The incubation period for the virus is roughly
two to fourteen days, and, therefore, patients who experience symptoms are strongly recommended to isolate
themselves for fourteen days (Deibie, 2020). Currently,
there are no proven drugs or vaccines to combat the
virus and thus prevent the spread. However, over the past
several months a great deal of covid-19 research has been
performed to meet the global demand. Researchers have
been experimenting with several anti-viral drugs that may

disrupt the viral proteins and ultimately stop the virus.
Additionally, there are numerous vaccines that are being
manufactured and researched that can possibly immunize
society and thereby stop the spread of the lethal virus.
Discussion
As noted, there is no current treatment which has proven to be effective in combatting the virus. Researchers
recognize that it is impossible to kill the virus and are,
therefore, working to “deactivate” the virus so that it
can not spread further. Dozens of pharmaceutical companies, as well as thousands of researchers are working
on producing a vaccine as well as seeking treatments and
medications to help combat the virus. Vaccines typically
contain an antigen, consisting a weakened or dead strain
of the virus. When introduced to the bloodstream, the
antigen triggers the immune system to produce antibodies towards that specific antigen. Researchers are trying
several methods to produce a vaccine in hope to find a
preventative cure for the lethal Coronavirus.
One approach that researchers are experimenting with
is with a DNA vaccine. A DNA vaccine simply delivers
genetic instructions how to build a viral protein. A DNA
vaccine does not introduce the entire virus to the body,
rather, it contains nucleotides that encode a portion of
the virus. Upon injection, the nucleotide travels to the
cell where it gets translated and a protein product is
produced in the form of messenger RNA. The mRNA
then assembles viral proteins which the immune system
recognizes and tries to conquer. Researchers in China
have used this approach and found particular genes that
code for the spikes in the coronavirus, specifically genes
which code for the receptor binding domain. The receptor binding domain is the unit of the virus that is found
externally and on surfaces and are, therefore, the primary
contributors for spreading the deadly virus. DNA plasmids are placed in the vaccine and, when injected into
the body, they target the genome upon which they are
translated into proteins, thereby introducing the cell to
traits of coronavirus which initiates the production of
antibodies. The cells then secrete the antibodies into the
bloodstream which stimulate the B and T cells to act accordingly (Lee et al, 2020). The advantage of DNA and
RNA vaccines is that they can be produced quicker than
typical vaccines. (The usage of DNA vaccines is an emerging field and is rapidly developing.)
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Another method that may be beneficial is the introduction of similar virus like particles into vaccines. These
particles are not actual viruses and therefore do not
cause disease. Yet, these particles prepare the immune
system for what the virus proteins look like so that it
can produce antibodies prior to coming in contact with
the actual virus. When combatting the coronavirus, some
researchers believe that by inserting some adenovirus
into the vaccine, it will familiarize the cell to traits of
coronavirus and thus prepare the body to fight off the
corona virus when the two encounter. The adenovirus
is missing one its own genes which prevents itself from
reproducing and is therefore nonhazardous. When the
adenovirus is injected, it places information into the cell
by unraveling the gene, which then stimulates the immune system to produce antibodies. A strand of DNA
that codes for coronavirus is inserted into the missing
genes which trigger the body’s immune response thus deactivating specific genes that are found in the coronavirus
(Khadilkar, 2020). This method has been effective for the
HPV vaccine that was introduced in 2006 and researchers are hopeful that this method will also be effective for
combating the coronavirus.
Antibiotics are generally used to fight bacterial infections and are, therefore, ineffective for coronavirus.
Accordingly, researchers are trying to create and find an
effective antiviral medication. There have been several
medications and treatments that have undergone trials
but not yet proven to combat the coronavirus.
In September 2020 international clinical trials tried
a new approach to combat the virus by using steroids.
Steroids are often used by doctors to alleviate inflammation as well as to relax the immune system to prevent an overresponse. Patients who are seriously ill from
coronavirus are at greater risk of dying from the immune
system’s overreaction to the virus, rather than from the
actual virus itself (Lee et al., 2020). Accordingly, researchers hope to treat these patients with steroids to relax
the body and prevent it from overreacting before the
inflammation becomes serious and, in some cases, fatal.
Researchers at Oxford University found that dexamethasone was extremely effective when given to critically
ill patients. In addition, the World Health Organization
(WHO) carried out studies using hydrocortisone and
methylprednisolone on critically ill patients. The steroids
were given to seriously ill patients and a surprising number of the patients did not require mechanical ventilation.
Moreover, death rates were lowered with the patients
who took these drugs (The Times, 2021). However, like
many other drugs, steroids can cause serious side effects
such as raising the body’s blood glucose levels and causing
6

confusion in the patient. Therefore, optimal doses of steroids need to be established prior to treating patients
with steroids on a larger scale. Nevertheless, many researchers are confident that steroids will eventually be an
effective tool in fighting the coronavirus.
Another approach to treating the coronavirus is with
the drug hydroxychloroquine. Hydroxychloroquine is a
less toxic derivative of chloroquine which was developed
decades ago to prevent and treat malaria (Liuzzo, 2020). It
is now commonly used for other diseases such as lupus
and rheumatoid arthritis. Hydroxychloroquine works
by regulating the immune system. The exact mechanism
through which hydroxychloroquine benefits Covid-19 patients is unclear. As mentioned earlier, many patients with
Covid-19 develop severe complications due to the body’s
aggressive immune response upon perceiving the virus.
Researchers are hopeful that hydroxychloroquine can prevent the immune system from over responding which will
in essence, reduce the unnecessary inflammation. Initially,
when the virus first reached the United States, the Food
and Drug Administration (FDA) approved the emergency
use of hydroxychloroquine. However, after experimenting
with the drug, researchers did not find sufficient supporting
evidence that it is a safe and effective treatment for coronavirus. A clinical study using hydroxychloroquine did not
demonstrate the ability to alleviate symptoms and shorten
hospital stays (Liuzzo, 2020). Therefore, in June 2020 the
FDA banned the usage of the drug until additional research
on safety and efficiency of the drug was performed. While
there is some evidence that the drug is effective, it has
not been estimated that the potential benefits outweigh
the risks. Some risks of hydroxychloroquine include heart
disease, headaches, dizziness, and vomiting. In addition, patients suffering from malaria and other diseases, who are
dependent on hydroxychloroquine, were unable to obtain
the drug because it had been used widely for patients suffering from Covid-19.
Another drug that is being experimented as a potential cure is Remdesivir. Remdesivir was first developed
in 2009, by Gilead Sciences to help treat patients suffering from Hepatitis C. Unfortunately, Remdesivir did not
prove to be effective in fighting against Hepatitis C. In the
following years, scientists experimented with Remdesivir
as a potential cure for Ebola, and then again in 2020 for
coronavirus (The New Nation, 2020.) Remdesivir serves
as a broad-spectrum antiviral medication that is used
to treat single stranded RNA viruses such as Ebola and
coronavirus. This class of medication targets and inhibits
RNA replication through various mechanisms (Nguyen
et al, 2020). In regard to coronavirus, Remdesivir works
as a pro-drug, meaning, that after it is infused, it is then
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metabolized into its active form and converted into a
ribonucleotide analogue, more specifically an adenine nucleotide analogue.
RNA is composed of four nucleotides including Adenine
(A), Guanine (G), Cytosine (C), and Uracil (U). When
coronavirus replicates, it takes these nucleotides that serve
as the building blocks for the virus, and then chains them
together thus allowing itself to replicate. Remdesivir serves
as an adenine nucleotide analogue, and therefore inhibits
viral replication. Thus, during viral replication attempts,
Remdesivir is incorporated into the RNA in place of adenine.This essentially stops transcription of the viral genome
by preventing the building blocks from being available to
properly form the virus. Moreover, it ultimately reduces
the body’s viral load which gives the body an opportunity
to combat the viral cells that were replicated prior to taking Remdesivir (Drugs and Therapies, 2020).
Currently, Remdesivir is in the investigational stage and
has not yet been FDA approved as a safe treatment for any
sort of disease. However, in May 2020, the FDA authorized
the emergency use of Remdesivir via intravenous (Drugs
and Therapies, 2020). Optimal doses of Remdesivir have
not yet established and are under investigation.
Another approach that is being tested is the usage of
convalescent plasma. When patients recover from Covid19 their blood plasma contains antibodies that are able to
fight off any future encounters with the virus. In the current situation, patients with antibodies who are eligible to
donate plasma do so and the plasma is then transfused
into a needy patient. The donor’s antibodies may aid the
patient in fighting off the virus as well as possibly shortening the length or severity of the illness. The concept of
convalescent plasma has been used widely for decades to
help patients recover from certain diseases such as chickenpox, measles and polio (Janice, 2020) (CotentEngine,
2020). Researchers still do not know how effective this
approach will be with the coronavirus. Nevertheless, the
FDA has approved the emergency usage of this treatment
option. There are currently multiple studies being run
that are testing the validity of this treatment. Although
the evidence is not completely clear, the FDA determined that convalescent plasma has a great likelihood
of improving symptoms as well as shortening hospital
stays. In addition, it is estimated that the potential benefits outweigh the possible risk factors of the treatment.
Risk factors include allergic reactions, lung damage and in
some cases pulmonary embolism (Sanfilippo et al. 2020).
These risk factors are low since donors must be completely recovered from the virus for at least two weeks
prior to donating plasma. Some doctors believe that this
is the most effective form of treatment when given to a

patient during the beginning stages of the virus in as early
as three days onset. (Newswire, 2020).
There are two categories of medicine- preventative
and curative. Preventative medicine aims to promote
and maintain health as well as prevent disease by living a
healthy lifestyle. Vaccines fall under this category because
they promote health by preventing disease and illnesses.
On the other hand, curative medicine seeks to aid individuals who have already contracted a disease and have
fallen ill, this includes treatment and medications. In regard
to coronavirus, there has not been a successful preventative or curative treatment plan proven mainly because the
virus has roughly 380 different mutations. Mutations occur
through viral replication.When the virus replicates, the genetic code does not always exactly duplicate resulting in
mutation. Over time, parts of the coronavirus genome have
expanded into many mutations which contributes to the
struggle that researchers are facing. Additionally, over time
new strains of viruses evolve. Researchers have not found
evidence that the different mutations and strains had significant change in how the virus affected society. However,
with new data being observed and recorded researchers
are optimistic that there will be a vaccine by the end of
2020 as a preventative measure towards the lethal virus.
Viruses are the most abundant biological entity on
earth. They are simple nucleotides consisting of genetic
material cased in a protein shell and capable of surviving
only in another living cell. When a virus enters a living
cell the immune system perceives the threat and begins
to battle it. However, in some instances the immune system is not trained to fight off a specific germ or virus,
causing the pathogen to overpower the immune system,
and cause illness. Once a pathogen suppresses the cell, it
replicates itself and kills the cell thus releasing particles
so that it can infect more healthy cells.
Researchers believe that when facing a new virus,
detection and containment are two keys that can help
fight it off. Experts realize that when they are dealing
with a new virus it is essential that they figure out the
gene sequence so that they can create test kits so doctors can test to see whether or not patients are infected
by that particular virus. After detection, containment is
vital, because once a virus reaches the human population
it spreads rapidly. Each virus has a different method of
spreading. Coronavirus in transmittable through respiratory droplets, mainly in the forms of spray such as coughing and sneezing. Researchers are doubtful the virus will
go away on its own and are, therefore, working to create
lines of defense such as vaccinations as well as seeking
proper treatment and medications. As discussed numerous researchers are working on producing a vaccine
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that can highly limit Covid-19 and potentially eradicate
it. However, vaccines need to go through strict testing
and experimenting before they become available to the
market. This process can take months and sometimes
even years. This contributes to the struggle researchers
are facing being that viruses are notorious for changing
and adapting to the environment, which makes it difficult
to nail down a precise vaccine. In addition, the WHO
is testing many drugs that are used for illnesses, but just
like vaccines this process can take a while. With all of this
on the rise, society is urged to stay calm and not panic.
Modern technology and further research prepare us
better than previous pandemics in history. Nevertheless,
the virus has had catastrophic consequences, however, if
people stay vigilant and quarantined when told to do so,
the spread of Covid-19 can be greatly slowed down until
a cure is found.
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